Status:
COMPLETED
Evaluation of Coagulopathy in Critically Ill COVID-19 Patients.
Lead Sponsor:
Assiut University
Conditions:
Coagulation Disorder
Eligibility:
All Genders
Brief Summary
Novel coronavirus disease 19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), this pneumonia was first emerged in December 2019 in Wuhan, China and rapidly spread ...
Eligibility Criteria
Inclusion
- COVID 19 critically ill patients
Exclusion
- any critical illness not related to COVID 19
Key Trial Info
Start Date :
July 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 16 2020
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04479280
Start Date
July 20 2020
End Date
August 16 2020
Last Update
September 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university
Asyut, Egypt, 71111